5 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Call for Applications: Innovator Awards Program for Inflammatory Bowel Disease Research
The Kenneth Rainin Foundation supports “out-of-the-box” innovative research projects that are potentially transformative to our efforts to diagnose, treat and/or cure Inflammatory Bowel Disease (IBD).
Through our Innovator Awards Program for IBD Research, we aim to reach out to all scientific disciplines from any non-profit research institution worldwide as a means to attract innovative researchers and encourage integrative cooperation across all disciplines in an effort to accomplish the Foundation’s mission of no one suffering from IBD.
Giving Guidelines for Health:
The Foundation supports projects that are in close alignment with its Awards Program criteria, which includes:
Innovation Scientific merit Strong evidence of collaboration High potential for success Funding projects that, due to their innovative nature, may not be eligible for funding from the National Institutes of Health (NIH) or other more traditional sources.
About the 2012 Innovator Awards Program for IBD Research
Letters of Inquiry (LOI) will be accepted online January 15 – February 15, 2012. The one-page LOI must include the basic idea and the central experiment. A biosketch will also be required. The Foundation’s Scientific Advisory Board will determine which applicants will be invited to submit a full application. Applicant selection will primarily be based on the project’s close alignment with the Innovator Awards Program’s criteria. Full applications, which will consist of an expanded LOI (up to three pages), two pages of science and a budget, will be due by May 1st.
The Innovator Awards Program is open to tenure track professors (or the equivalent) at all levels from any scientific discipline and from any non-profit research institutions worldwide. Interdisciplinary collaboration is strongly encouraged.
About the Breakthrough Awards Program for IBD Research
The Breakthrough Awards Program is designed to provide longer term support to existing KRF-funded Innovator Award recipients that have demonstrated significant “proof of principle” research progress validating their original innovative hypotheses. KRF Innovator Awardees are evaluated for potential Breakthrough Awards at the end of their initial year of funding at the KRF’s Annual SAB meeting.
The Kenneth Rainin Foundation is located in Oakland, California. Please direct your questions to info@krfoundation.org. As we strive to be a paperless office, email is the preferred method of communication. If you cannot email, please leave a message at 510-625-5207 and we will return your call as soon as possible.
Crohn's and Colitis Foundation of America Senior Research Awards
Letter of Intent to Apply Due May 1
Direct Costs: $117,000 per year Indirect Costs: 10% of direct costs or $11,700 Duration of Award: One to Three Years
Objective: To provide established researchers with funds to generate sufficient preliminary data to become competitive for funds from other sources, such as the National Institute of Health (NIH).
Applicant Eligibility: Applicant must hold an MD, PhD, or equivalent degree and must be employed by an institution (public non-profit, private non-profit or government) engaged in health care and/or health related research. He/she must have attained independence from his/her mentor. Eligibility is not restricted by citizenship or geography.
Proposal Eligibility: Proposal MUST be relevant to inflammatory bowel disease (Crohn's Disease or ulcerative colitis). Only one application is allowed per applicant per submission date. Simultaneous submission of a Senior Research Award and a Training Award is not permitted.
Crohn's & Colitis Foundation of America 386 Park Avenue South 17th Floor New York, NY 10016 Phone: 800-932-2423 E-mail: info@ccfa.org
Crohn's and Colitis Foundation of America Research Fellowship Awards
Total Award: Up to $58,250 per year Duration of Award: One to Three Years
Objective: Research Fellowship Awards are offered to encourage the development of individuals with research potential to help them prepare for a career of independent basic and/or clinical investigation in the area of Crohn's disease and ulcerative colitis.
Applicant Eligibility: Individuals who are already well established in the field of IBD research are not considered eligible for this award. Applicant must be employed by an institution (public non-profit, private non-profit or government) engaged in health care and/or health related research within the United States. Research is not restricted by citizenship; however, proof of legal work status is required. Applicant must hold an MD, PhD or equivalent. Candidates holding MD degrees must have two years of post doctoral experience, one year of which must be documented research experience relevant to IBD. Applicants holding PhDs must have at least one year of documented post-doctoral research relevant to IBD.
Proposal Eligibility: Proposal MUST be relevant to inflammatory bowel disease (Crohn's Disease or ulcerative colitis). Only one application is allowed per applicant per submission date. Simultaneous submission of a Senior Research Award and a Research Training Award is not permitted.
Time Commitment: The awardee must devote a minimum of 90% of his/her time directly to the project.
Stipend & Institutional Allowance: Award salary will match applicants institutional salary (salaries may be supplemented by the applicant's institution), depending on postgraduate year (PGY) level, up to $45,000 per year. Fringe benefits are allowed according to institutional policy, not to exceed 25% of the salary award (up to $11,250 per year). CCFA will also provide up to $2,000 to be used for non-salary/fringe expenses directly related to the project, including travel to scientific meetings and/or professional membership dues. These funds may not be used to supplement the awardee's salary/fringe benefits.
Crohn's and Colitis Foundation of America Career Development Awards
Total Award: Up to $90,000 per year Duration of Award: One to Three Years
Objective: Career Development Awards are offered to encourage the development of individuals with research potential to help them prepare for an career of independent basic and/or clinical investigation in the area of inflammatory bowel disease. Therefore, individuals who are already well established in the field of IBD research are not considered eligible for this award.
Applicant Eligibility: Applicant must be employed by an institution (public non-profit, private non-profit or government) engaged in health care and/or health related research within the United States. Research is not restricted by citizenship; however, proof of legal work status is required. Applicant must hold an MD, PhD or equivalent. Candidates holding MD degrees must have five years of post doctoral experience, two years of which must be documented research experience relevant to IBD. Generally, the candidates must not be in excess of ten years beyond the attainments of the doctoral degree. Applicants holding PhDs must have at least two years of documented post-doctoral research relevant to IBD.
Time Commitment: The awardee must devote a minimum of 80% of his/her time directly to the project
Stipend & Institutional Allowance: Award salary will match applicants institutional salary (salaries may be supplemented by the applicant's institution), depending on postgraduate year (PGY) level, up to $52,000 per year. Fringe benefits are allowed according to institutional policy, must not exceed 25% of the salary award (up to $13,000 per year). CCFA will also provide up to $25,000 to be used for non-salary/fringe expenses such as an MPH degree or equivalent tuition (all degrees must be completed in the three year window of this award) or statistical support, travel to professional meetings, professional memberships, and textbooks. These funds may not be used to supplement the awardee's salary/fringe benefits.
Broad Medical Research Program Inflammatory Bowel Disease Grants
Recognizing that some of the most promising research in this area of medicine is at the very early stages of development, the Broad Medical Research Program funds studies and investigation of new ideas in their initial exploratory stage that do not yet qualify for funding from more traditional sources like the National Institutes of Health. By supporting innovative and promising ideas, we hope to advance the research so it is likely to receive continuation funding from other sources. The Broad Medical Research Program awards one- and two-year grants for basic or clinical IBD research projects to qualified investigators from around the world who work in a nonprofit academic organization. Grant applications submitted to the Broad Medical Research Program are not reviewed by a committee. Instead, leading investigators in each research area review proposals and provide suggestions for improvement. Over 1,900 reviewers from 41 countries have participated in the review process. Proposals are selected for funding based on their scientific strength, innovation and relevance to IBD diagnosis, therapy or prevention. To expedite the research, we accept applications year-round and fund approved applications in about three months.Because we believe that great ideas could come from non-traditional sources, we encourage basic and clinical investigators and scientists not currently working in IBD and interdisciplinary teams to apply.Application ProcessThere is a two-step process for requesting funds from the Broad Medical Research Program:1. The first step is to submit a Letter of Interest. Decisions on Letters of Interest are based on external expert review of the proposal and usually are made within four to six weeks. Instructions for Letters of Interest can be found at www.broadmedical.org.2. If we are interested in pursuing a project, an invitation is extended to submit a full grant application. At that time, the grant application instructions and forms are sent to the Principal Investigator. Decisions on grant applications are made based on external review by subject experts and usually take eight to 10 weeks.There are no deadlines or specific dates for applications. Proposals are accepted and reviewed year-round.Proposal Review• Most Letters of Interest and all grant applications will be evaluated by active investigators in the specific research area.• Reviewers are located throughout the world and are chosen carefully not to have conflicts of interest with the applicants.• Grant proposals will be selected for funding based on their scientific strength, innovative value and relevance to IBD diagnosis, therapy or prevention.• Decisions on Letters of Interest will usually be made within 4-6 weeks.• Decisions on grant applications will usually be made within 8-10 weeks.Funding Guidelines• Preference is given to proposals with strong potential of clinical benefit to IBD patients in the foreseeable future.• Funding can be requested for up to two years.• Funding of a second year will be based on an evaluation of the progress and the perceived value of the findings from the first year of funding.
Letter of Interest Submission 1. Direct Letters of Interest to: Daniel Hollander, M.D. Director Broad Medical Research Program The Eli and Edythe Broad Foundation, Scientific | Medical Research 10900 Wilshire Boulevard, Twelfth Floor Los Angeles, California 90024-6532 U.S.A. 2. If possible, please send your Letter of Interest and all attachments electronically to: info@broadmedical.org. If you send it electronically, please do not send a printed copy. 3. Receipt of your Letter of Interest will be acknowledged by e-mail within a few days. If you do not hear from us in a timely manner, please contact us at info@broadmedical.org to make sure that your letter has been received. 4. You may include suggestions for potential reviewers and also indicate individuals with potential conflicts of interest. Unless required by your institution, Letters of Interest may be submitted directly to the BMRP by the Principal Investigator and do not require institutional approval or signature. 5. Letters of Interest are accepted and reviewed throughout the year; there are no deadlines.
1
